Mepolizumab targets multiple immune cells in aspirin-exacerbated respiratory disease-Reference-Cited by-同舟云学术

Mepolizumab targets multiple immune cells in aspirin-exacerbated respiratory disease

Published:2021-08 Issue:2 Volume:148 Page:574-584
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Buchheit Kathleen M.,Lewis Erin,Gakpo Deborah,Hacker Jonathan,Sohail Aaqib,Taliaferro Faith,Berreondo Giron Evans,Asare Chelsea,Vukovic Marko,Bensko Jillian C.,Dwyer Daniel F.,Shalek Alex K.,Ordovas-Montanes Jose,Laidlaw Tanya M.

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference69 articles.

1. Assessing the additional disease burden of polyps in chronic rhinosinusitis;Bhattacharyya;Ann Otol Rhinol Laryngol,2009

2. Depression symptoms and lost productivity in chronic rhinosinusitis;Campbell;Ann Allergy Asthma Immunol,2017

3. Medical and surgical considerations in patients with Samter's triad;McMains;Am J Rinol,2006

4. Cytokines in chronic rhinosinusitis. role in eosinophilia and aspirin-exacerbated respiratory disease;Stevens;Am J Respir Crit Care Med,2015

5. Dexpramipexole depletes blood and tissue eosinophils in nasal polyps with no change in polyp size;Laidlaw;Laryngoscope,2019

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Twice-Yearly Depemokimab in Severe Asthma with an Eosinophilic Phenotype;New England Journal of Medicine;2024-09-09

2. Interleukin-5-Hemmung mit vielen Effekten;Pneumo News;2024-06-27

3. Real-Life Evidence of Mepolizumab Treatment in Chronic Rhinosinusitis with Nasal Polyps: A Multicentric Study;Journal of Clinical Medicine;2024-06-18

4. Dupilumab dampens mucosal type 2 response during acetylsalicylic acid challenge in N-ERD patients;2024-06-07

5. Absolute eosinophil counts in aspirin-exacerbated respiratory disease are distinctly elevated and correlate inversely with respiratory function;The Journal of Allergy and Clinical Immunology: In Practice;2024-05